课题基金 / 基金详情

Molecular Basis of Novel Membrane Transport Mechanism

Molecular Basis of Novel Membrane Transport Mechanism
新型膜传输机制的分子基础
批准号:
15GS0301
负责人:
INAGAKI Nobuya
金额:
$309.17万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Creative Scientific Research
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2007

项目摘要

项目成果

INAGAKI Nobuya的其他基金

相似基金

相关文献

中文摘要
翻译
本研究的目的是通过研究ABC蛋白在膜运输中的功能,以及它们的结构和病理生理作用,来阐明新型膜运输机制的分子基础。在本研究中1)通过研究ABCA3在患者和ABCA3缺陷小鼠中的功能和病理生理,我们确定ABCA3在肺表面活性物质的产生和板层体生物形成中起关键作用,可能通过将这些脂质作为底物运输。2)我们克隆了ABCA2的全长cDNA,发现ABCA2在脑白质区高水平表达,主要在少突胶质细胞中表达。此外,我们在使用ABCA2缺乏的小鼠时发现,ABCA2参与脑内鞘脂的细胞内代谢,特别是鞘磷脂和神经节脂苷GM1。3)我们测定了纯化的ABCA1的ATP水解活性,证明了它优先受到磷脂酰胆碱的刺激。此外,ABCG1介导的胆固醇的更多外排依赖于细胞鞘磷脂水平,并与鞘磷脂的外排相关,这表明ABCA1和ABCG1在HDL形成中的协同作用。4) ABC蛋白如何处理大量具有不同结构和分子量的疏水化合物,即磷脂和胆固醇的机制尚不清楚。我们证明了胆固醇在底物识别中发挥重要作用,特别是通过MDR1,当小药物与底物结合时,胆固醇会填补底物结合位点的空白,并提出了胆固醇填充模型。5)确定了调节型ABC蛋白SUR的功能和病理生理作用。在Kir6.2缺陷小鼠中,我们发现含有kir6.2的KATP通道在维持缺氧喘息和降低呼吸频率中起关键作用。此外,我们已经证明含有kir6.1的KATP通道参与了大脑小动脉中神经活动调节的血液流动。6)建立了纯化人MDR1蛋白的体系,该体系将用于获得晶体结构。此外,基于gfp融合蛋白的定位,预测ABC蛋白结晶能力的系统已经开发出来。通过对19个ABC蛋白的筛选,我们获得了3个蛋白的晶体,其中2个将适合分析X射线晶体结构。此外,我们建立了大规模制备和纯化KATP通道(SUR1-Kir 6.2复合物),并获得了纯化和负染色的SUR1-Kir 6.2复合物的电镜图。少
英文摘要
Our aim in this study is to clarify the molecular basis of novel membrane transport mechanisms by investigating not only functions of ABC proteins in membrane transport but also on their structures and pathophysiological roles. In this study1) By investigating the function and pathophysiology of ABCA3 in patients and ABCA3-deficient mice, we determined that ABCA3 is critical in pulmonary surfactant production and lamellar body biogenesis, probably by transporting these lipids as substrates.2) We cloned a full-length cDNA of ABCA2, and showed that ABCA2 is expressed at high levels in brain white matter regions, mainly in oligodendrocytes. In addition, we showed using ABCA2-defiocient mice, that ABCA2 is involved in the intracellular metabolism of sphingolipids, particularly sphingomyelin and gangliosides GM1, in the brain.3) We measured the ATP hydrolysis activity of purified ABCA1 and demonstrated that it is stimulated preferentially by phosphatidylcholine. In addition, ABCG1-mediated … More efflux of cholesterol is dependent on the cellular sphingomyelin level and correlates with the efflux of sphingomyelin, suggesting the cooperative roles of ABCA1 and ABCG1 in HDL formation.4) The mechanism how ABC proteins handle enormous numbers of hydrophobic compounds with various structures and molecular weights, or phospholipids and cholesterol, is not known. We demonstrated that cholesterol plays an important role in substrate recognition, especially by MDR1, where cholesterol fills the empty space in the substrate binding site when small drugs bind to it, and proposed the cholesterol fill-in model.5) The function and pathophysiological role of regulator-type ABC protein, SUR, are determined. Using Kir 6.2-deficient mice, we showed that Kir6.2-containing KATP channels are critically involved in the maintenance of hypoxic gasping and depression of respiratory frequency. Furthermore, we have shown that Kir6.1-containing KATP channels are involved in the neural activity-regulated blood flow in small arterioles in the brain.6) The system to purify human MDR1 protein which will be used in obtaining crystal structure has been established. In addition, the system to predict the ability of ABC proteins to crystallize based on the localization of the GFP-fused proteins has been developed. By screening 19 ABC proteins, we obtained the crystal of 3 proteins, 2 of which will be suitable to analyze the X ray crystal structure. Furthermore, we have established large-scale preparation and purification of KATP channel (SUR1-Kir 6.2 complex), and obtained the electron microscopy of purified and negatively stained SUR1-Kir 6.2 complex. Less
期刊论文(238)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.bbamcr.2005.10.006
发表时间: 2005-12-15
期刊: BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
影响因子: 5.1
作者: [Kashiwayama, Y, Asahina, K, Imanaka, T]
通讯作者: Imanaka, T
Effect of PCB-126 on intracellular accumulation and transepithelial transport of vinblastine in LLC-PK1 and its transformant cells expressing human P-glycoprotein.
PCB-126 对表达人 P-糖蛋白的 LLC-PK1 及其转化细胞中长春花碱的细胞内积累和跨上皮转运的影响。
DOI: --
发表时间: 2004
期刊: J.Vet.Med.Sci. 66
影响因子: --
作者: [Sasawatari, S., et al.]
通讯作者: et al.
DOI: --
发表时间: 2008
期刊:
影响因子: --
作者: [崎山慶太, 木村泰久, 小段篤史, 中津亨, 植田和光, 加藤博章]
通讯作者: 加藤博章
Functional Analysis of lipid transporter ABCG1
脂质转运蛋白ABCG1的功能分析
DOI: --
发表时间: 2006
期刊:
影响因子: --
作者: [Kobayashi, A., Takanezawa, Y., Hirata, T., Shimizu, Y., Kioka, N., Arai, H., Ueda, K., Matsuo, M.]
通讯作者: M.
共 163 条
    Development of a noninvasive method for beta cell mass measurement using a nuclear magnetic resonance
    • 批准号:
      25670258
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      INAGAKI Nobuya
    • 依托单位:
    Development of the novel diagnostic method for quantification ofpancreatic beta-cell mass by magnetic resonance imaging
    • 批准号:
      22390185
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $11.98万
    • 财政年份:
      2010
    • 负责人:
      INAGAKI Nobuya
    • 依托单位:
    Structure and physiological role of ATP-sensitive potassium channel
    • 批准号:
      11470009
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.02万
    • 财政年份:
      1999
    • 负责人:
      INAGAKI Nobuya
    • 依托单位:
    Development of drugs which open or close ATP-sensitive KィイD1+ィエD1channels
    • 批准号:
      10557002
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.1万
    • 财政年份:
      1998
    • 负责人:
      INAGAKI Nobuya
    • 依托单位:
    国内基金
    海外基金
    子宫内膜间质与巨噬细胞之间通过Protein S-MerTK-Apelin信号对 话促进子宫腺肌病蜕膜化缺陷的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      吕海宁
    • 依托单位:
    有翅与无翅蚜虫差异分泌唾液蛋白Cuticular protein在调控植物细胞壁免疫中的功能
    • 批准号:
      32372636
    • 项目类别:
      面上项目
    • 资助金额:
      50.00万元
    • 批准年份:
      2023
    • 负责人:
      郭慧娟
    • 依托单位:
    原发性开角型青光眼中SIPA1L1促进小梁网细胞外基质蛋白累积升高眼压的作用机制
    • 批准号:
      82371054
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      郭涛
    • 依托单位:
    胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
    • 批准号:
      82370976
    • 项目类别:
      面上项目
    • 资助金额:
      48.00万元
    • 批准年份:
      2023
    • 负责人:
      郑凌艳
    • 依托单位: